Adverum Biotechnologies, Inc. Increase (Decrease) in Other Operating Assets
Adverum Biotechnologies, Inc. reported Increase (Decrease) in Other Operating Assets of -$143.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2023-11-09
- Adverum Biotechnologies, Inc. increase (decrease) in other operating assets for the quarter ending 2023-09-30 was -$38.00K.
- Adverum Biotechnologies, Inc. increase (decrease) in other operating assets for the quarter ending 2023-06-30 was -$43.00K, a 102.46% decline year-over-year.
- Adverum Biotechnologies, Inc. increase (decrease) in other operating assets for the quarter ending 2023-03-31 was -$62.00K, a 103.74% decline year-over-year.
- Adverum Biotechnologies, Inc. increase (decrease) in other operating assets for the quarter ending 2022-09-30 was -$4.27M, a 42770.00% decline year-over-year.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month |
|---|---|---|---|
| 2023-09-30 | -$38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$81.00K derived: sum of 2 quarters · filed 2023-11-09 | -$143.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$105.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$62.00K 10-Q · filed 2023-05-11 | ||
| 2022-09-30 | -$4.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$2.52M derived: sum of 2 quarters · filed 2023-11-09 | -$864.00K 10-Q · filed 2023-11-09 |
| 2022-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $3.40M 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $1.66M 10-Q · filed 2023-05-11 | ||
| 2021-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$355.00K derived: sum of 2 quarters · filed 2022-11-10 | $109.00K 10-Q · filed 2022-11-10 |
| 2021-06-30 | -$365.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $99.00K 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $464.00K 10-Q · filed 2022-05-12 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $8.00K 10-Q · filed 2021-11-04 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $8.00K 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $8.00K 10-Q · filed 2021-05-06 | ||
| 2019-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$18.00K derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $18.00K 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $18.00K 10-Q · filed 2020-05-28 |